Sangal Papers Downgraded to 'Sell' by MarketsMOJO: Weak Fundamentals and High Debt Raise Concerns

Apr 23 2024 06:16 PM IST
share
Share Via
Sangal Papers, a microcap company in the paper and paper products industry, has been downgraded to a 'Sell' by MarketsMojo due to weak long-term fundamental strength, slow growth in net sales and operating profit, and a high debt to EBITDA ratio. Recent financial performance and inconsistent returns also raise concerns for investors.
Sangal Papers Downgraded to 'Sell' by MarketsMOJO: Weak Fundamentals and High Debt Raise Concerns
Sangal Papers, a microcap company in the paper and paper products industry, has recently been downgraded to a 'Sell' by MarketsMOJO on April 23, 2024. This decision was based on several factors, including weak long-term fundamental strength, poor growth in net sales and operating profit, and a high debt to EBITDA ratio.
In the last 5 years, Sangal Papers has only seen an average Return on Capital Employed (ROCE) of 7.58%, indicating a weak long-term fundamental strength. Additionally, the company's net sales have only grown at an annual rate of 6.50%, while its operating profit has only grown at 0.61%. This lack of growth is a concerning factor for investors. Furthermore, the company's high debt to EBITDA ratio of 3.93 times suggests a low ability to service debt. This can be a red flag for investors, especially in times of market downturns. In terms of recent financial performance, Sangal Papers has reported flat results in December 2023, with a -41.67% growth in PAT (9M) and the lowest NET SALES (Q) at Rs 45.56 crore. Additionally, 38.76% of the promoter shares are pledged, which can put additional downward pressure on the stock prices in falling markets. On a positive note, the stock is currently in a mildly bullish range and has multiple bullish factors, such as MACD, Bollinger Band, and KST. It also has an attractive valuation with a ROCE of 4.2 and a 0.8 Enterprise value to Capital Employed. However, it is currently trading at a discount compared to its average historical valuations. In the past year, Sangal Papers has generated a return of 42.32%, but its profits have fallen by -38.2%. This inconsistency in returns is a cause for concern for investors. Despite these factors, Sangal Papers has consistently outperformed the BSE 500 index in the last 3 annual periods, which may be a positive sign for long-term investors. However, considering the current market conditions and the company's weak long-term fundamentals, MarketsMOJO has downgraded the stock to a 'Sell'. Investors are advised to carefully evaluate their investment decisions and consider all the factors before making any decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News